-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KrQ1XC2t1RYfXqZc9O2YM27QCjSwTa0ZIY4Px4Nf8DYYcoeaFiyTU19gHps18nAV
 p2Ml3nKstZaXc/PSG0NfBw==

<SEC-DOCUMENT>0000000000-05-058078.txt : 20060925
<SEC-HEADER>0000000000-05-058078.hdr.sgml : 20060925
<ACCEPTANCE-DATETIME>20051116133946
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000000000-05-058078
CONFORMED SUBMISSION TYPE:	UPLOAD
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20051116

FILED FOR:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		UPLOAD

	BUSINESS ADDRESS:	
		STREET 1:		508 LAPP ROAD
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		4849131200

	MAIL ADDRESS:	
		STREET 1:		508 LAPP ROAD
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
PUBLIC REFERENCE ACCESSION NUMBER:		0000950133-05-001054
</SEC-HEADER>
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>


Via Facsimile and U.S. Mail
Mail Stop 6010


November 16, 2005


Mr. Dennis W. Genge
Chief Financial Officer, Vice President
Novavax, Inc.
508 Lappa Road
Malvern, PA 19355

Re:	Novavax, Inc.
	Form 10-K for Fiscal Year Ended December 31, 2004
	Filed March 15, 2005
	File No.  000-26770

Dear Mr. Genge,

      We have completed our review of your Form 10-K and related
filings and have no further comments at this time.

						Sincerely,


								Joel Parker
								Accounting Branch Chief


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----